title: Rituximab-induced fatal interstitial pneumonitis: case report.
authors.forename: C
authors.initials: C
authors.lastname: Vulsteke
authors.forename: D
authors.initials: D
authors.lastname: Dierickx
authors.forename: E
authors.initials: E
authors.lastname: Verbeken
authors.forename: P
authors.initials: P
authors.lastname: Wolter
authors.forename: J
authors.initials: J
authors.lastname: Thomas
authors.forename: P
authors.initials: P
authors.lastname: Schöffski
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000633:toxicity*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000401:mortality*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008297:Male; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab